Once BCG unresponsive, always BCG unresponsive: An open letter to the FDA to enhance recruitment into clinical trials in bladder cancer

Ashish M. Kamat, Seth Lerner, Peter Black, Joaquim Bellmunt, Colin Dinney, Noah Hahn, Michael O'Donnell, Diane Z. Quale

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)145-146
Number of pages2
JournalBladder Cancer
Volume3
Issue number3
DOIs
StatePublished - Jan 1 2017

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this